A study to assess the safety, tolerability, and pharmacokinetics of AZD9550 following single ascending dose administration to healthy participants

Trial Identifier: D8460C00001
Sponsor: AstraZeneca
Start Date: May 2023
Primary Completion Date: November 2023
Study Completion Date: November 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.